Page 1 of 62
123Next ›Last »

2022

Wells QS, Farber-Eger E, Lipworth L, Dluzniewski P, Dent R, Umejiego J, Cohen SS. 2022. Characterizing a clinical trial — Representative, real-world population with heart failure with reduced ejection fraction. Clin Epidemiol (open access), Dove Press.

View Abstract

Thompson CM, Bhat VS, Brorby GP, Haws LC. 2021. Development of updated RfD and RfC values for medium carbon range aromatic and aliphatic total petroleum hydrocarbon fractions. J Air Waste Manag Assoc 71(12):1555–1567, doi: 10.1080/10962247.2021.1974123.

View Abstract

2021

Mavunda K, Jiang X, Ambrose CS. 2021. Prevalence and clinical characteristics of perinatal chronic lung disease by infant gestational age. J Neonatal Perinatal Med 14(1):43–51, doi: 10.3233/NPM-200412.

View Abstract

Röth A, Fryzek J, Jiang X, Reichert H, Patel P, Su J, Morales Arias J, Broome CM. 2021. Complement-mediated hemolysis persists year round in patients with cold agglutinin disease. Transfusion [online] 1–9; doi: 10.1111/trf.16745.

View Abstract

Franke K, Payne L, Franzen A, Wikoff D, Henderson R. 2021. Cannabidiol literature scoping review protocol. Center for Open Science, OSFHOME (May 20).

View Abstract

Blanchette AD, Burnett SD, Grimm FA, Rusyn I, Chiu WA. 2020. A Bayesian method for population-wide cardiotoxicity hazard and risk characterization using an in vitro human model. Toxicol Sci 178(2):391–403, doi: 10.1093/toxsci/kfaa151. PMID: 33078833.

View Abstract

Stan SV, Grathwohl D, O’Neill LM, Saavedra JM, Butte NF, Cohen SS. 2021. Estimated energy requirements of infants and young children up to 24 months of age. Curr Dev Nutr 5(11):1–9.

View Abstract

Racz L, Rish W. 2021. Exposure monitoring toward environmental justice. Integ Environ Assess Manag 00:1–5; available online.

View Abstract

Black MB, Andersen ME, Pendse SN, Borghoff SJ, Streicker M, McMullen PD. 2021. RNA-sequencing (transcriptomic) data collected in liver and lung of male and female B6C3F1 mice exposed to various dose levels of 4-methylimidazole for 2, 5, or 28 days. Data in Brief 38:107420. doi: 10.1016/j.dib.2021.107420. PMID: 34660856; PMCID: PMC8502903.

View Abstract

Palermo CM, Foreman JE, Wikoff DS, Lea I. 2021. Development of a putative adverse outcome pathway network for male rat reproductive tract abnormalities with specific considerations for the androgen sensitive window of development. Curr Res Toxicol 22:2:254–271. doi: 10.1016/j.crtox.2021.07.002. PMID: 34401750; PMCID: PMC8350458.

View Abstract
Page 1 of 62
123Next ›Last »